{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:53:12Z","timestamp":1793533992560,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpag.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:12:08Z","timestamp":1759299128000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hidradenitis Suppurativa in the Pediatric and Adolescent Population"],"prefix":"10.1016","volume":"39","author":[{"given":"Natalie","family":"Hickerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Lev-Tov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Danker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-9510","authenticated-orcid":false,"given":"Judith","family":"Simms-Cendan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0001","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.jpag.2025.09.007_bib0002","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-061049","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"151","author":"Cotton","year":"2023","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jpag.2025.09.007_bib0003","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bjd.14038","article-title":"Diagnostic delay in hidradenitis suppurativa is a global problem","volume":"173","author":"Saunte","year":"2015","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jpag.2025.09.007_bib0004","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jid.2018.04.001","article-title":"Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jpag.2025.09.007_bib0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamadermatol.2020.5435","article-title":"Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients","volume":"157","author":"Liy-Wong","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0006","doi-asserted-by":"crossref","first-page":"e086","DOI":"10.1097\/JW9.0000000000000086","article-title":"Pain management and emergency care in adolescent patients with hidradenitis suppurativa: a cross-sectional hospital-based study","volume":"9","author":"Park","year":"2023","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaad.2021.06.843","article-title":"Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa","volume":"86","author":"Wright","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0008","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jpag.2025.09.007_bib0009","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/jcm14030910","article-title":"Impact of hidradenitis suppurativa on sexual quality of life","volume":"14","author":"Caliezi","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpag.2025.09.007_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.960488","article-title":"Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation","volume":"13","author":"Chopra","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jpag.2025.09.007_bib0011","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2265.2003.01858.x","article-title":"Adrenarche - physiology, biochemistry and human disease","volume":"60","author":"Auchus","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0012","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaad.2020.08.045","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"86","author":"Choi","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0013","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.det.2021.12.004","article-title":"Hormonal treatment of acne and hidradenitis suppurativa in adolescent patients","volume":"40","author":"Svoboda","year":"2022","journal-title":"Dermatol Clin"},{"issue":"23","key":"10.1016\/j.jpag.2025.09.007_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315250","article-title":"The role of hormones in Hidradenitis Suppurativa: a systematic review","volume":"23","author":"Abu Rached","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2023.04.044","article-title":"Prevalence of polycystic ovarian syndrome among children and adolescents with hidradenitis suppurativa","volume":"89","author":"Mastacouris","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0017","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaad.2019.08.034","article-title":"Association between obesity and hidradenitis suppurativa among children and adolescents: a population-based analysis in the United States","volume":"82","author":"Balgobind","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jpag.2025.09.007_bib0018","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"gamma-secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0019","doi-asserted-by":"crossref","DOI":"10.2196\/33391","article-title":"Common dermatologic disorders in Down syndrome: systematic review","volume":"5","author":"Lam","year":"2022","journal-title":"JMIR Dermatol"},{"issue":"12","key":"10.1016\/j.jpag.2025.09.007_bib0020","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jamadermatol.2022.4564","article-title":"Evaluation of hidradenitis suppurativa diagnostic criteria in pediatric patients","volume":"158","author":"Kittler","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0032","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/09546634.2019.1621981","article-title":"Non-pharmacologic approaches for hidradenitis suppurativa - a systematic review","volume":"32","author":"Hendricks","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.jpag.2025.09.007_bib0021","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40272-023-00595-6","article-title":"Hidradenitis suppurativa in children and adolescents: an update on pharmacologic treatment options","volume":"25","author":"Chiang","year":"2023","journal-title":"Paediatr Drugs"},{"issue":"1","key":"10.1016\/j.jpag.2025.09.007_bib0022","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jaad.2023.08.064","article-title":"Clascoterone in the treatment of mild hidradenitis suppurativa","volume":"90","author":"Hargis","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jpag.2025.09.007_bib0023","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.jpag.2025.09.007_bib0024","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","article-title":"Finasteride for the treatment of hidradenitis suppurativa in children and adolescents","volume":"149","author":"Randhawa","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jpag.2025.09.007_bib0038","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.36849\/JDD.2020.5447","article-title":"Metformin as adjunctive therapy for pediatric patients with hidradenitis suppurativa","volume":"19","author":"Moussa","year":"2020","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ijd.15124","article-title":"Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa","volume":"60","author":"Garelik","year":"2021","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jpag.2025.09.007_bib0031","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pde.15331","article-title":"Efficacy of procedural treatments for pediatric hidradenitis suppurativa: a systematic review","volume":"40","author":"Masson","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jamadermatol.2021.4741","article-title":"Patient impressions and outcomes after clinic-based hidradenitis suppurativa surgery","volume":"158","author":"Ravi","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jpag.2025.09.007_bib0028","first-page":"23","article-title":"Hidradenitis suppurativa: surgery, lasers, and emerging techniques","volume":"42","author":"Maskan Bermudez","year":"2023","journal-title":"Surg Technol Int."},{"issue":"5","key":"10.1016\/j.jpag.2025.09.007_bib0026","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1208\/s12248-019-0363-5","article-title":"Model-informed drug development approach supporting approval of Adalimumab (HUMIRA) in adolescent patients with hidradenitis suppurativa: a regulatory perspective","volume":"21","author":"Bi","year":"2019","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.jpag.2025.09.007_bib0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","article-title":"Bacteriology of hidradenitis suppurativa - which antibiotics are the treatment of choice?","volume":"94","author":"Matusiak","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0027","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/12034754211049711","article-title":"Biologic use in pediatric patients with hidradenitis suppurativa: a systematic review","volume":"26","author":"Sachdeva","year":"2022","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.jpag.2025.09.007_bib0033","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/lsm.23796","article-title":"Efficacy of laser hair removal in hidradenitis suppurativa: a systematic review and meta-analysis","volume":"56","author":"Shipman","year":"2024","journal-title":"Lasers Surg Med"},{"issue":"5","key":"10.1016\/j.jpag.2025.09.007_bib0034","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40257-020-00537-9","article-title":"Botulinum toxin type B for Hidradenitis Suppurativa: a randomised, double-blind, placebo-controlled pilot study","volume":"21","author":"Grimstad","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2021.09.058","article-title":"Wound dressings improve quality of life for hidradenitis suppurativa patients","volume":"86","author":"Schneider","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0036","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.det.2024.12.010","article-title":"Addressing the dressings: wound care in hidradenitis suppurativa","volume":"43","author":"Hickerson","year":"2025","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jpag.2025.09.007_bib0037","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.18692","article-title":"The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials","volume":"183","author":"Kirby","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318825003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318825003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:35:20Z","timestamp":1770122120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318825003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1083318825003559"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2025.09.007","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis Suppurativa in the Pediatric and Adolescent Population","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}